Anti-COVID-19 analyses of new marine sulfated glycans revealed promising anti-COVID-19 effects primarily mediated via competitive inhibition of S-protein binding with the host cell surface HS proteoglycans. The gene discussed is PROS1; the disease is COVID-19.